263 related articles for article (PubMed ID: 28854728)
21. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
Lobo R; Soerdal T; Ekerhovd E; Cohlen B; Porcu E; Schenk M; Shufaro Y; Smeenk J; Suerdieck MB; Pinton P; Pinborg A;
Hum Reprod; 2024 May; ():. PubMed ID: 38723189
[TBL] [Abstract][Full Text] [Related]
22. Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze).
Maheshwari A; Bell JL; Bhide P; Brison D; Child T; Chong HY; Cheong Y; Cole C; Coomarasamy A; Cutting R; Hardy P; Hamoda H; Juszczak E; Khalaf Y; Kurinczuk JJ; Lavery S; Linsell L; Macklon N; Mathur R; Pundir J; Raine-Fenning N; Rajkohwa M; Scotland G; Stanbury K; Troup S; Bhattacharya S
Hum Reprod; 2022 Mar; 37(3):476-487. PubMed ID: 34999830
[TBL] [Abstract][Full Text] [Related]
23. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
24. Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial.
Bülow NS; Skouby SO; Warzecha AK; Udengaard H; Andersen CY; Holt MD; Grøndahl ML; Nyboe Andersen A; Sopa N; Mikkelsen ALE; Pinborg A; Macklon NS
Hum Reprod; 2022 Jan; 37(2):309-321. PubMed ID: 34792133
[TBL] [Abstract][Full Text] [Related]
25. A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial.
Jacob SL; Brewer C; Tang T; Picton HM; Barth JH; Balen AH
Hum Reprod; 2016 Dec; 31(12):2756-2764. PubMed ID: 27816925
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering.
Gambini S; Sonigo C; Robin G; Cedrin-Durnerin I; Vinolas C; Sifer C; Boumerdassi Y; Mayeur A; Gallot V; Grynberg M; Peigné M
Hum Reprod; 2024 May; 39(5):963-973. PubMed ID: 38452353
[TBL] [Abstract][Full Text] [Related]
27. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B;
Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013
[TBL] [Abstract][Full Text] [Related]
28. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
29. Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial.
Zhang S; Tang Y; Wang X; Zong Y; Li X; Cai S; Ma H; Guo H; Song J; Lin G; Lu G; Gong F
Hum Reprod; 2022 Jun; 37(7):1431-1439. PubMed ID: 35460400
[TBL] [Abstract][Full Text] [Related]
30. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study.
Haas J; Bassil R; Samara N; Zilberberg E; Mehta C; Orvieto R; Casper RF
Hum Reprod; 2020 Jul; 35(7):1648-1654. PubMed ID: 32563188
[TBL] [Abstract][Full Text] [Related]
31. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
32. Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.
Popovic-Todorovic B; Santos-Ribeiro S; Drakopoulos P; De Vos M; Racca A; Mackens S; Thorrez Y; Verheyen G; Tournaye H; Quintero L; Blockeel C
Hum Reprod; 2019 Oct; 34(10):2027-2035. PubMed ID: 31560740
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
34. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
[TBL] [Abstract][Full Text] [Related]
35. A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCG.
Lainas GT; Lainas TG; Sfontouris IA; Venetis CA; Kyprianou MA; Petsas GK; Tarlatzis BC; Kolibianakis EM
Hum Reprod Open; 2020; 2020(3):hoaa013. PubMed ID: 32529046
[TBL] [Abstract][Full Text] [Related]
36. Follicular flushing increases the number of oocytes retrieved: a randomized controlled trial.
Lainas GT; Lainas TG; Makris AA; Xenariou MV; Petsas GK; Kolibianakis EM
Hum Reprod; 2023 Oct; 38(10):1927-1937. PubMed ID: 37632249
[TBL] [Abstract][Full Text] [Related]
37. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
[TBL] [Abstract][Full Text] [Related]
38. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
39. The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation.
Maslow BL; Guarnaccia M; Stefanacci C; Ramirez L; Klein JU
Hum Reprod; 2020 May; 35(5):1054-1060. PubMed ID: 32406915
[TBL] [Abstract][Full Text] [Related]
40. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.
Humaidan P; Nelson SM; Devroey P; Coddington CC; Schwartz LB; Gordon K; Frattarelli JL; Tarlatzis BC; Fatemi HM; Lutjen P; Stegmann BJ
Hum Reprod; 2016 Sep; 31(9):1997-2004. PubMed ID: 27343272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
